UPDATE : Friday, December 6, 2019
“Xalkori-Alecensa sequential therapy advantageous in duration of treatment”
Given the licensing and insurance system in Korea, the Xalkori-Alecensa seq...
by Kim Yun-mi  |  2019-11-15 17:48
Ministry revokes Kolon Life Science’s innovative drug company status
The Ministry of Health and Welfare revoked Kolon Life Science’s innovative ...
by Lee Han-soo  |  2019-11-15 17:26
Regulator presents guideline for smart contact lens measuring blood sugar
The Ministry of Food and Drug Safety said that it has set up a new guidelin...
by Lee Han-soo  |  2019-11-15 15:22
Seegene posts ₩31.4 billion in Q3 sales
Seegene recorded sales of 31.4 billion won ($26.9 million) in the third qua...
by Lee Han-soo  |  2019-11-15 13:50
AbbVie presents new data for ankylosing spondylitis treatment in US
AbbVie has presented positive data from its phase 2 and 3 SELECT-AXIS 1 tri...
by Lee Han-soo  |  2019-11-15 11:40
JW Medical sells Hitachi's ultrasound scanner device
JW Medical, a subsidiary of JW Holdings, said that it has begun to market A...
by Lee Han-soo  |  2019-11-15 11:39
Merck Korea wins award for helping families with infertility problems
Merck Biopharma Korea said that it received the National Assembly's Hea...
by Lee Han-soo  |  2019-11-14 18:05
Huons to sell Insightec's MRI-guided ultrasound system in Korea
Huons said that it would market the Israeli medical device company Insighte...
by Lee Han-soo  |  2019-11-14 17:06
'DTC genetic testing service providers should improve quality of information'
The direct-to-consumer (DTC) genetic testing market has grown exponentially...
by Lee Han-soo  |  2019-11-14 15:27
Prosecutors raid drugmakers, distributors for suspected bid-rigging
Prosecutors have begun investigating local drug companies and distributors ...
by Jeong Sae-im  |  2019-11-14 15:27
71.5% of doctors experience verbal, physical attack from patients
Seven out of 10 physicians said they have been attacked verbally or physica...
by Choi Gwang-seok  |  2019-11-14 15:25
‘Novartis’ Kymriah takes one step closer to cancer cure’
Novartis has recently drawn the attention of local industry watchers concer...
by Lee Han-soo  |  2019-11-14 13:24
‘AI will not replace doctors but help improve their workload’
Artificial intelligence (AI) is now the hottest keyword in the biomedical s...
by Lee Han-soo  |  2019-11-14 11:50
Will Biogen be 1st to get FDA nod for Alzheimer’s drug?
Biogen recently unveiled the new results of studies on aducanumab, an inves...
by Kim Yun-mi  |  2019-11-14 11:23
iCure to apply for testing incrementally modified cancer drugs in US
iCure BNP said that it plans to apply for a phase 1 trial to change antican...
by Lee Han-soo  |  2019-11-13 17:35
JW Pharmaceutical launches joint-stock company in Vietnam
JW Pharmaceutical said that it has formally launched Euvipharm Joint Stock ...
by Lee Han-soo  |  2019-11-13 16:52
World Diabetes Day event raises public awareness of disease
It was 20 years ago that Jang, a career soldier, was first diagnosed with t...
by Lee Han-soo  |  2019-11-13 15:53
‘Generic drugs must indicate ingredient names on label’
“The results of ranitidine’s recall were sharply different from those of va...
by Kim Yun-mi  |  2019-11-13 15:51
How can Korean drugmakers enter Europe successfully?
Officials from the Korea Pharmaceutical and Bio-Pharma Manufacturers Associ...
by Jeong Sae-im  |  2019-11-13 15:22
Samsung Bioepis expects ₩1 trillion biosimilar sales this year
Samsung Bioepis said it was confident of achieving 1 trillion won ($855.8 m...
by Jeong Sae-im  |  2019-11-13 15:21
Back to Top